Join to View Full Profile
685 W Baltimore StRoom 480Baltimore, MD 21201
Phone+1 410-706-6554
Dr. Neuzil is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
VanderbiltMPH, 1996 - 1998
Johns Hopkins University School of MedicineClass of 1987
Certifications & Licensure
MD State Medical License 2015 - 2025
WA State Medical License 1998 - 2019
TN State Medical License 1989 - 1999
Clinical Trials
- Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi Start of enrollment: 2018 Feb 21
- Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4 Start of enrollment: 2018 Feb 20
- Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants Start of enrollment: 2019 Jan 24
Publications & Presentations
PubMed
- Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controll...Meagan E Deming, Elizabeth R Brown, Monica A McArthur, Stephanie J Schrag, Melissa Arvay
The Lancet. Microbe. 2025-04-01 - An intranasal adjuvanted, recombinant influenza A/H5 vaccine candidate induces broad priming against diverse influenza A/H5N1 virus clades in a phase I randomized tria...Meagan E Deming, Franklin R Toapanta, Marcela Pasetti, Hana Golding, Surender Khurana
Research Square. 2025-03-05 - Immunogenicity and reactogenicity of a booster dose of a typhoid conjugate vaccine (TCV) in Malawian pre-school children.Nginache Nampota-Nkomba, Osward M Nyirenda, Shrimati Datta, Victoria Mapemba, Priyanka D Patel
Eclinicalmedicine. 2025-03-01
Journal Articles
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesEdward E Walsh, Robert W Frenck, Ann R Falsey, Judith Absalon, Kathleen Neuzil, Vanessa Raabe, Philip R Dormitzer, The New England Journal of Medicine
- Accelerating Development of SARS-CoV-2 Vaccines — the Role for Controlled Human Infection ModelsMeagan E Deming, Kathleen M Neuzil, The New England Journal of Medicine
- The Effect of Pre-Existing Immunity on Virus Detection and Immune Responses in a Phase II Randomized Trial of a Russian-Backbone Live Attenuated Influenza Vaccine in B...Peter F Wright, Justin R Ortiz, Kathleen M Neuzil, Clinical Infectious Diseases
Authored Content
- Accelerating Development of SARS-CoV-2 Vaccines — the Role for Controlled Human Infection ModelsJuly 2020
- Accelerating Development of SARS-CoV-2 Vaccines — the Role for Controlled Human Infection ModelsJuly 2020
- Accelerating Development of SARS-CoV-2 Vaccines — the Role for Controlled Human Infection ModelsJuly 2020
Press Mentions
UM School of Medicine Researchers Chart Path Forward on Developing mRNA Vaccines for Infections Beyond COVID-19April 5th, 2023- Covid Vaccines Prevented 3 Million Deaths in the U.S., New Analysis FindsDecember 20th, 2022
- Three University of Maryland School of Medicine Faculty Members Honored by Baltimore Business JournalNovember 1st, 2022
- Join now to see all
Grant Support
- COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL COREUNIVERSITY OF MARYLAND BALTIMORE2019–2025
- COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS: CLINICAL COREUNIVERSITY OF MARYLAND BALTIMORE2019–2025
- COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL COREUNIVERSITY OF MARYLAND BALTIMORE2019–2025
- COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL COREUNIVERSITY OF MARYLAND BALTIMORE2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
